We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
MaxLinear
MXL
$6.8B
| $522K | 0.08% |
15,358
+5,721
| +59% | +$240K |
|
477
Cimpress
CMPR
$2.31B
| $520K | 0.08% |
13,365
-5,518
| -29% | -$269K |
|
|
VSTO
478
DELISTED
Vista Outdoor Inc.
VSTO
| $519K | 0.08% |
18,599
+5,075
| +38% | +$181K |
|
479
IDEX
IEX
$17.3B
| $517K | 0.08% |
+2,847
| New | +$536K |
|
480
IQVIA
IQV
$39.3B
| $517K | 0.08% |
+2,383
| New | +$517K |
|
|
MTOR
481
DELISTED
MERITOR, Inc.
MTOR
| $517K | 0.08% |
14,217
+8,206
| +137% | +$295K |
|
482
Clean Harbors
CLH
$16.3B
| $515K | 0.08% |
5,880
+3,115
| +113% | +$301K |
|
483
LyondellBasell Industries
LYB
$19.2B
| $515K | 0.08% |
5,886
+735
| +14% | +$76.6K |
|
|
KBAL
484
DELISTED
Kimball International
KBAL
| $515K | 0.08% |
67,101
+38,888
| +138% | +$318K |
|
485
Ocular Therapeutix
OCUL
$2.02B
| $514K | 0.08% |
127,978
+70,358
| +122% | +$266K |
|
486
Rogers Corp
ROG
$2.4B
| $514K | 0.08% |
+1,961
| New | +$521K |
|
487
Kinross Gold
KGC
$32.8B
| $512K | 0.08% |
+143,055
| New | +$692K |
|
|
SBNY
488
DELISTED
Signature Bank
SBNY
| $512K | 0.08% |
2,855
+1,093
| +62% | +$245K |
|
489
Federal Signal
FSS
$7.83B
| $510K | 0.08% |
14,316
+3,829
| +37% | +$132K |
|
|
COWN
490
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $510K | 0.08% |
21,541
-471
| -2% | -$11.4K |
|
491
Viper Energy
VNOM
$14.7B
| $508K | 0.08% |
19,034
-12,896
| -40% | -$392K |
|
492
Black Stone Minerals
BSM
$3B
| $507K | 0.08% |
37,019
-59,695
| -62% | -$906K |
|
493
Pultegroup
PHM
$25.3B
| $507K | 0.08% |
12,785
+2,724
| +27% | +$115K |
|
494
Xencor
XNCR
$1.55B
| $505K | 0.08% |
+18,439
| New | +$455K |
|
|
HYZN
495
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $505K | 0.08% |
+3,432
| New | +$727K |
|
496
Lyft
LYFT
$6.63B
| $504K | 0.08% |
+37,961
| New | +$885K |
|
|
HTLF
497
DELISTED
Heartland Financial USA, Inc.
HTLF
| $504K | 0.08% |
+12,138
| New | +$534K |
|
498
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $503K | 0.08% |
+14,726
| New | +$460K |
|
499
Kimbell Royalty Partners
KRP
$1.48B
| $503K | 0.08% |
32,087
-10,026
| -24% | -$174K |
|
500
AGNC Investment
AGNC
$12.9B
| $502K | 0.08% |
+45,329
| New | +$537K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.